PubMed=2790824
Julius Klominek, Karl-Henrik Robert, Anders Hjerpe, Bo Wickstrom, Gosta Gahrton;
Serum-dependent growth patterns of two, newly established human mesothelioma cell lines.
Cancer Res. 49:6118-6122(1989)

PubMed=7662316; DOI=10.1139/o95-007
George N. Tzanakakis, Nikos K. Karamanos, Julius Klominek, Anders Hjerpe;
Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis.
Biochem. Cell Biol. 73:59-66(1995)

PubMed=9310181; DOI=10.1016/S0300-9084(97)80026-0
George N. Tzanakakis, Anders Hjerpe, Nikos K. Karamanos;
Proteoglycan synthesis induced by transforming and basic fibroblast growth factors in human malignant mesothelioma is mediated through specific receptors and the tyrosine kinase intracellular pathway.
Biochimie 79:323-332(1997)

PubMed=23840376; DOI=10.1371/journal.pone.0065903; PMCID=PMC3688685
Adam Szulkin, Gustav Nilsonne, Filip Mundt, Agata M. Wasik, Pega Souri, Anders Hjerpe, Katalin Dobra;
Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.
PLoS ONE 8:e65903.1-e65903.14(2013)

PubMed=33567673; DOI=10.3390/cancers13040685; PMCID=PMC7915464
Maureen Keller, Katarina Reis, Anders Hjerpe, Katalin Dobra, Pontus Aspenstrom;
Cytoskeletal organization correlates to motility and invasiveness of malignant mesothelioma cells.
Cancers (Basel) 13:685.1-685.20(2021)